Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05104619

Spectroscopic Analysis of Tongue Tumor Samples.

In squamous cell carcinoma of the tongue, complete surgical resection of the tumor generally represents the primary treatment strategy. Among factors determining the disease prognostic, the surgical margins status is essential for the continued management of the patient, with or without complementary therapies. Generally, surgical margins are defined using visual and tactile elements. Unfortunately, in 15 to 30 percent of cases, they are defined as positive after histopathological examination, on average 5 to 7 days post-surgery.

Techniques have recently been developed to analyze the cancerous and non-cancerous nature of tissues, using the spectral properties of tumor cells. SpiderMass™ is an instrument equipped with a probe for tissue micro-sampling and real-time molecular profile analysis. It is thus ultimately a tool for anatomopathological decision support, for diagnosis and prognosis of the disease. Used in the operating room, SpiderMass™ could also become an innovative surgical tool to precisely define cancerous areas in situ and the margins status in intraoperative conditions.

Based on the principle of artificial intelligence, the SpiderMass™ machine must initially learn to recognize pathological tissues versus healthy. This project aims to accomplish this first phase of machine learning for squamous cell carcinoma of the tongue.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Centre Hospitalier Universitaire d'Amiens

Amiens, Picardie, 80000, France

Location status: Recruiting

Location contact

Christophe ATTENCOURT, MD

CONTACT

[email protected]

03 22 66 87 66

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age : 18 years and older
  • squamous cell carcinoma of the tongue
  • surgical resection as first-line treatment
  • tumor classification T1 to T4.

Exclusion criteria

  • metastatic disease
  • neoadjuvant therapies

Treatment and study plan

tongue surgery

Procedure

In squamous cell carcinoma of the tongue, complete surgical resection of the tumor

Primary outcomes

  1. Tumor cells detection in tongue tumor with SpiderMass technique

    Time frame: 1 year

    Tumor cells detection in tongue tumor with SpiderMass technique

Study contacts

Contact information is provided by the study sponsor or research team.

Christophe ATTENCOURT, MD

CONTACT

[email protected]

03 22 66 87 66

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire, Amiens

Other

Collaborators

  • Université de Lille

Registry information

Official study title

Prospective Analysis of Tumor Tissues From the Oral Cavity by SpiderMassTM Spectroscopy

Acronym: SpecTum

Important dates

Study start
2021
Primary completion
2026
Study completion
2026
First posted
Nov 3, 2021
Registry last updated
Jun 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.